Synapse - Vincent Miller

Search Within

Vincent Miller

Results (64)

Molecular analysis of NSCLC patients with acquired resistance to gefitinib or erlotinib

Meeting Abstract

Pao, W.; Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

EGFR mutation and copy number, EGFR protein expression and KRAS mutation as predictors of outcome with erlotinib in bronchioloalveolar cell carcinoma (BAC): Results of a prospective phase II trial

Meeting Abstract

Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Ladanyi, M.; Tsao, A. S.; Sandler, A.; Herbst, R.; Kris, M. G.; Johnson, D. H.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

EGFR mutation analysis in 334 consecutive non-small cell lung cancers: Evidence for frequent amplification of the mutant EGFR allele and survival correlations of mutation type

Meeting Abstract

Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Ma, Y. Y .; Miller, V. A.; Kris, M. G.; Ladanyi, M.
Modern Pathology (2006)

Fulltext@MSK | Save

EGFR mutation analysis in 334 consecutive non-small cell lung cancers: Evidence for frequent amplification of the mutant EGFR allele and survival correlations of mutation type

Meeting Abstract

Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Ma, Y. Y .; Miller, V. A.; Kris, M. G.; Ladanyi, M.
Laboratory Investigation (2006)

Fulltext@MSK | Save

Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas

Journal Article

Pham, D. K.; Kris, M. G.; Riely, G. J.; Sarkaria, I. S.; McDonough, T.; Chuai, S. K.; Venkatraman, E. S.; Miller, V. A.; Ladanyi, M.; Pao, W.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib

Journal Article

Riely, G. J.; Pao, W.; Pham, D.; Li, A. R.; Rizvi, N.; Venkatraman, E. S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Miller, V. A.
Clinical Cancer Research (2006)

Fulltext@MSK | Save

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors

Journal Article

Balak, M. N.; Gong, Y.; Riely, G. J.; Somwar, R.; Li, A. R.; Zakowski, M. F.; Chiang, A.; Yang, G.; Ouerfelli, O.; Kris, M. G.; more...
Clinical Cancer Research (2006)

Fulltext@MSK | Save

A prospective study to correlate EGFR mutations with gefitinib response in early stage NSCLC

Meeting Abstract

Rizvi, N.; Pao, W.; Miller, V.; Rusch, V.; Heelan, R.; Ladanyi, M.; Ginex, P.; Tyson, L.; Zakowski, M.; Kris, M.
Lung Cancer (2005)

Fulltext@MSK | Save

Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib

Meeting Abstract

Riely, G. J.; Miller, V. A.; Pao, W.; Zakowski, M.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

EGFR mutation, immumohistochemistry (IHC) and chromogenic in situ hybridization (CISH) as predictors of sensitivity to erlotinib and gefitinib in patients (pts) with NSCLC

Meeting Abstract

Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Hussain, S.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save